Sergio Cantoreggi
Chief Tech/Sci/R&D Officer at Helsinn Healthcare SA
Network origin in Sergio Cantoreggi first degree
Entity | Entity type | Industry | |
---|---|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Helsinn Birex Pharmaceuticals Ltd.
Helsinn Birex Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Helsinn Birex Pharmaceuticals Ltd. develops and manufactures oral dosage drug products. It is engaged in providing oral solid dosage forms and topical forms of pharmaceutical products and packaging of sterile products. The firm supplies its partners with ready to sell products on an exclusive basis, which are manufactured on site and using a network of external manufacturing partners. The company was founded by Gabriele Braglia on May 18, 1978 and is headquartered in Dublin, Ireland.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sergio Cantoreggi via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EUROCINE VACCINES AB | Pharmaceuticals: Major | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member | |
Bär & Karrer AG
Bär & Karrer AG Miscellaneous Commercial ServicesCommercial Services Bär & Karrer is a leading Swiss law firm. They advise its clients on a broad range of business law issues. They are committed to delivering prompt advice and innovative solutions to its clients. With more than 120 lawyers they regularly handle complex transactions and litigation providing a flexible and individualized service. For every project, they use specialized teams in order to efficiently assist its clients. They serve clients ranging from multinational corporations to private individuals both in Switzerland and globally. In a global economy, legal issues rarely stop at national boundaries; as a result, the majority of its work has an international component. They have an extensive international network of correspondent law firms, which are market leaders in their jurisdiction. They have offices in the three main language areas of Switzerland (Zurich, Zug, Lugano and Geneva). | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Indiana University | College/University | Masters Business Admin | |
West Virginia University | College/University | Undergraduate Degree | |
New York Philharmonic
New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Movies/Entertainment | Consultant / Advisor | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
University of Pavia | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
University of Lisbon | College/University | Doctorate Degree | |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Quanta Dialysis Technologies Ltd.
Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
Helsinn Holding SA
Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Chief Executive Officer Founder Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
BSP Pharmaceuticals SpA
BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology BSP Pharmaceuticals SpA develops and manufactures anticancer drugs. It offers development, clinical supply, commercial supply, and analytical services. The company was founded by Aldo Braca in July 2006 and is headquartered in Latina Scalo, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Warburg Pincus International LLC | Investment Managers | Private Equity Investor | |
Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA. | Pharmaceuticals: Major | Director/Board Member | |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
NIOX GROUP PLC | Medical/Nursing Services | Chairman | |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor | |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chief Executive Officer | |
AAAS Fellowship Programs, Inc.
AAAS Fellowship Programs, Inc. Insurance Brokers/ServicesFinance AAAS Fellowship Programs, Inc. provides health insurance services. The company is headquartered in Washington, DC. | Insurance Brokers/Services | Corporate Officer/Principal | |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Chief Executive Officer | |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor Chairman Private Equity Investor Private Equity Investor | |
Greenbone Ortho SRL
Greenbone Ortho SRL BiotechnologyHealth Technology Greenbone Ortho SRL develops a wood-derived bone implants technology to generate biomimetic implant suitable to address non-union fractures. It offers GreenBone that reproduce chemical composition and thee-dimensional architecture of natural tissues. The company was founded by Lorenzo Pradella in 2014 and is headquartered in Faenza, Italy. | Biotechnology | Director/Board Member Director/Board Member | |
FSI SGR SpA
FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
QuantuMDx Group Ltd.
QuantuMDx Group Ltd. Electronic Equipment/InstrumentsElectronic Technology QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Helsinn SA | Director/Board Member Chairman | ||
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Micromega Ltd.
Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Micromega Ltd. provides business support services. The private company is based in London, UK. The British company was founded by Francesco Granata. | Miscellaneous Commercial Services | Founder | |
Fondazione per la ricerca sul cancro nel Ticino | Director/Board Member | ||
3B Future Health Fund II S.C. A. SICAV-RAIF
3B Future Health Fund II S.C. A. SICAV-RAIF Investment ManagersFinance 3B Future Health Fund II S.C. A. SICAV-RAIF invests in companies located in the US, Europe, Israel and Japan. The fund target companies operating in the fields of healthcare. It provides financing for early stage capital requirements with an investment up to USD 12 million. It also makes follow on investment and take a seat on the board of director. | Investment Managers | Chairman | |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
Laboratorios Biofarma SA | Sales & Marketing | ||
National Centre For Research & Development /Poland/
National Centre For Research & Development /Poland/ Miscellaneous Commercial ServicesCommercial Services The National Centre for Research and Development in Poland provides executive agency services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Gui Sheng Tang Sinomedica Holding SA | Director/Board Member |
Statistics
International
United States | 13 |
United Kingdom | 10 |
Switzerland | 9 |
Italy | 8 |
Sweden | 4 |
Sectoral
Health Technology | 23 |
Consumer Services | 8 |
Finance | 8 |
Commercial Services | 6 |
Health Services | 3 |
Operational
Director/Board Member | 82 |
Corporate Officer/Principal | 31 |
Chairman | 16 |
Chief Executive Officer | 12 |
Founder | 10 |
Most connected contacts
Insiders | |
---|---|
Lonnie Moulder | 31 |
Riccardo Braglia | 29 |
Francesco Granata | 24 |
Roberto de Ponti | 16 |
Eric Cornut | 14 |
Carlos von Bonhorst | 10 |
Siddharth Kaul | 6 |
Melanie Rolli | 5 |
Giorgio Edoardo Calderari | 4 |
Paolo Bottini | 4 |
Paolo Ferrari | 3 |
Gabriele Edoardo Braglia | 3 |
Luigi Caletti | 3 |
Padraig Somers | 1 |
Andrew Hayes | 1 |
- Stock Market
- Insiders
- Sergio Cantoreggi
- Company connections